Pricing Log in Create free account

Polaryx Therapeutics, Inc. (PLYX) vs Seer, Inc. (SEER)

Polaryx Therapeutics, Inc. and Seer, Inc. are both Biotechnology companies. Polaryx Therapeutics, Inc. and Seer, Inc. are of similar size ($94.1M and $89.7M). Polaryx Therapeutics, Inc. has the higher net margin (0.00% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 12 metrics below, Polaryx Therapeutics, Inc. leads on 9 and Seer, Inc. on 3.

Valuation

Metric PLYX SEER Biotechnology median
P/E n/m n/m 10.26
P/S n/m 6.36 9.18
P/B 7.94 0.40 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.97 0.65
EV/Sales n/m (4.39) 8.98
Earnings yield (12.03%) (74.39%) (34.89%)
Free cash flow yield (9.48%) (48.61%) (24.52%)

Profitability

Metric PLYX SEER Biotechnology median
Gross margin — 47.70% 65.16%
Operating margin 0.00% (498.19%) 0.00%
Net margin 0.00% (478.05%) 0.00%
Free cash flow margin 0.00% (309.34%) 0.00%
Return on equity 0.00% (26.45%) (50.12%)
Return on assets (169.05%) (23.47%) (45.60%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric PLYX SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 6.26%
EPS growth (last fiscal year) 77.72% 7.91% 29.88%
Revenue growth, 5-year CAGR — 90.78% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric PLYX SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.53 14.74 4.89
Net debt to EBITDA 0.66 2.63 1.01

Dividend

Metric PLYX SEER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PLYX SEER Biotechnology median
Market cap 89.72m 94.13m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack